Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice

Vaccine

Volumn 24, Issue 47-48, 2006, Pages 6886-6892

  Lee, John S ^a   Groebner, Jennifer L ^a   Hadjipanayis, Angela G ^a   Negley, Diane L ^a   Schmaljohn, Alan L ^a   Welkos, Susan L ^a   Smith, Leonard A ^a   Smith, Jonathan F ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Anthrax; Botulinum neurotoxin; Marburg virus; Multiagent vaccine; Vaccine; VEE replicon; VEEV; Venezuelan equine encephalitis virus; Virus vector

Indexed keywords

ANTHRAX VACCINE; BACTERIAL VACCINE; BOTULINUM TOXIN HC FRAGMENT; BOTULINUM TOXIN HC FRAGMENT MARBURG VIRUS GLYCOPROTEIN; BOTULINUM TOXIN HC FRAGMENT MATURE PROTECTIVE ANTIGEN; BOTULINUM TOXIN HC FRAGMENT MATURE PROTECTIVE ANTIGEN MARBURG VIRUS GLYCOPROTEIN; BOTULINUM TOXOID VACCINE; MARBURG VIRUS GLYCOPROTEIN; MATURE PROTECTIVE ANTIGEN; MATURE PROTECTIVE ANTIGEN MARBURG VIRUS GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BACILLUS ANTHRACIS; BOTULISM; CONTROLLED STUDY; IMMUNE RESPONSE; INOCULATION; MARBURG VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPLICON; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS HEMORRHAGIC FEVER; VIRUS PARTICLE; VIRUS VECTOR;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, VIRAL; BOTULINUM TOXINS; CAPSID PROTEINS; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; MARBURGVIRUS; MICE; MICE, INBRED CBA; NEUROTOXINS; REPLICON; VACCINES, CONJUGATE; VIRAL VACCINES;

EID: 33846207973     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.004     Document Type: Article

References (32)

1. Investigation of bioterrorism-related anthrax: Connecticut. Morb Mortal Wkly Rep 50 48 (2001) 1077-1079
2. Pushko P., Parker M., Ludwig G.V., Davis N.L., Johnston R.E., and Smith J.F. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterlogous pathogens in vivo. Virology 239 (1997) 389-401
3. Inglesby T.V., O'Toole T., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., et al. Anthrax as a biological weapon, 2002: updated recommendations for management. J Am Med Assoc 287 17 (2002) 2236-2252
4. In: Kortepeter M., Christopher G.W., Cieslak T.J., Culpepper R., Darling R., Pavlin J.A., et al. (Eds). USAMRIID's medical management of biological casualties handbook. 4th ed. (2001), US Government Printing Office, Washington, DC
5. Flick-Smith H.C., Walker N.J., Gibson P., Bullifent H., Hayward S., Miller J., et al. A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection. Infect Immun 70 3 (2002) 1653-1656
6. Fowler K., McBride B.W., Turnbull P.C.B., and Baillie L.W.J. Immune correlates of protection against anthrax. J Appl Microbiol 87 (1999) 305
7. Ivins B.E., Fellows P., Pitt L., Estep J., Farchaus J., Friedlander A., et al. Experimental anthrax vaccine: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine 13 18 (1995) 1779-1784
8. Pitt M.L.M., Little S., Ivins B., Fellows P., Barth J., Hewetson J., et al. In vitro correlate of immunity in a rabbit model of inhalation anthrax. Vaccine 19 (2001) 4768-4773
9. Shlyakhov E., Rubinstein E., and Novikov I. Anthrax post-vaccinal cell-mediated immunity in humans: kinetic patterns. Vaccine 15 6/7 (1997) 631-636
10. Friedlander A., Welkos S.L., and Ivins B. Anthrax vaccines. Curr Top Microbiol Immunol 271 (2002) 33-60
11. Little S.F., Webster W.M., Ivins B., Fellows P., Norris S.L., and Andrews G.P. Development of an in vitro-based potency assay for anthrax vaccine. Vaccine 22 21/22 (2004) 2843-2852
12. Welkos S.L., Friedlander A., Weeks S., Little S., and Mendelson I. In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effect of anti-PA antibody. J Med Microbiol 51 10 (2002) 821-831
13. Cote C., Rossi C.A., Kang A., Morrow P., Lee J.S., and Welkos S.L. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microb Pathog 38 (2005) 209-225
14. Lee J.S., Hadjipanayis A.G., and Welkos S.L. Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge. Infect Immun 71 3 (2003) 1491-1496
15. Hatheway C.L. Botulism. In: Balows A., Hausler W.J., Ohashi M., and Turano A. (Eds). Laboratory diagnosis of infectious diseases: principles and practice (1988), Springer-Verlag New York, Inc., New York, NY 111-133
16. Sugiyama H. Clostridial botulinum neurotoxin. Microbiol Rev 44 3 (1980) 419-448
17. Tacket C.O., and Rogawski M.A. Botulism. In: Simpson L.L. (Ed). Botulinum neurotoxin and tetanus toxin (1989), Academic Press, Inc., San Diego, CA 351-378
18. Smith L.A. Development of recombinant vaccines for botulinum neurotoxin. Toxicon 36 11 (1998) 1539-1548
19. Clayton M.A., Clayton J.M., Brown D.R., and Middlebrook J.L. Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed froma synthetic gene in Escherichia coli. Infect Immun 63 7 (1995) 2738-2742
20. Byrne M.P., Smith T.J., Montgomery V.A., and Smith L.A. Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate. Infect Immun 66 10 (1998) 4817-4822
21. Byrne M.P., Titball R.W., Holley J., and Smith L.A. Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris. Protein Exp Purif 18 3 (2000) 327-337
22. Montgomery V.A., Makuch R.S., Brown J.E., and Hack D.C. The immunogenicity in humans of a botulinum type F vaccine. Vaccine 18 (2000) 728-735
23. Lee J.S., Pushko P., Parker M.D., Dertzbaugh M.T., Smith L.A., and Smith J.F. Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system. Infect Immun 69 9 (2001) 5709-5715
24. Peters C.J., Sanchez A., Rollin P.E., Ksiazek T.G., and Murphy F.A. Filoviridae: Marburg and Ebola viruses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields virology (1996), Lippincott-Raven Publishers, Philadelphia 1161-1176
25. Sanchez A., Khan A.S., Zaki S.R., Nabel G.J., Ksiazek T.G., and Peters C.J. Filoviridae: Marburg and Ebola viruses. In: Knipe D.M., Howley P.M., Griffin D.E., Martin M.A., Lamb R.A., Roizman B., et al. (Eds). Fields virology (2001), Lippincott-Raven Publishers, Philadelphia 1279-1304
26. Riemenschneider J., Garrison A., Geisbert J., Jahrling P., Hevey M., Negley D., et al. Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus, and Venezuelan equine encephalitis virus. Vaccine 21 (2003) 4071-4080
27. Hevey M., Negley D., VanderZanden L., Tammariello R.F., Geisbert J., Schmaljohn C., et al. Marburg virus vaccines: comparing classical and new approaches. Vaccine 20 (2002) 586-593
28. Hevey M., Negley D., Pushko P., Smith J., and Schmaljohn A. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology 251 (1998) 28-37
29. Lee J.S., Dyas B.K., Nystrom S.S., Lind C.M., Smith J.F., and Ulrich R.G. Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon. J Infect Dis 185 (2002) 1192-1196
30. Lee J.S., Pushko P., Parker M.D., Dertzbaugh M.T., Smith L.A., and Smith J.F. Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system. Infect Immun 69 9 (2001) 5709-5715
31. Hevey M., Negley D., Geisbert J., Jahrling P.B., and Schmaljohn A.L. Antigenicity and vaccine potectial of Marburg virus glycoprotein expressed by baculovirus recombinants. Virology 239 (1997) 206-216
32. Iacono-Connors L.C., Welkos S.L., Ivins B.E., and Dalrymple J.M. Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals. Infect Immun 59 6 (1991) 1961-1965